Company & Sponsor Intelligence
Loma Linda University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting0
Completed3
Countries1
Therapeutic footprint
anxietyautismdepressionparkinsonsstroke
Indexed studies
NCT05382039Effects of Electrotherapy on Pain, Anxiety, Motion and Disability in Adults With Neck or Upper Body Pain.
anxiety · United StatesNA
anxiety · United StatesNA
NCT03912896Taekwondo for Children With Autism Spectrum Disorder
autism · United StatesNA
autism · United StatesNA
NCT04283058Low Dose Ketamine Infusion for the Treatment of Resistant Depression
depression · United StatesWITHDRAWN
depression · United StatesWITHDRAWN
NCT02524015Novel Treatment For Pusher Syndrome Using Physical Therapy
stroke · NA
stroke · NA
NCT02162979Sildenafil (Viagra) for the Treatment of Dyskinesias in Parkinson's Disease
parkinsons · United StatesPHASE2
parkinsons · United StatesPHASE2
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →